Brief: Gain Therapeutics Inc. Reports Third Quarter 2022 Financial Results, Business Update
10/11/2022 22:19
Nov 10 (Reuters) - Gain Therapeutics Inc GANX.O :
* GAIN THERAPEUTICS, INC. REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND BUSINESS UPDATE
* QTRLY GAAP BASIC AND DILUTED NET LOSS PER SHARE WAS $0.38
* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE
$25.7
MILLION AS OF SEPTEMBER 30, 2022
* Q3 EARNINGS PER SHARE VIEW $-0.46 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7z1z8B
Further company coverage: GANX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gain Therapeutics
See all newsU.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Gain Therapeutics climbs on narrower-than-expected quarterly loss
Gain Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall